White Mark Andrew bought RCKT
February 16, 2024 · Form 4 insider transaction
White Mark Andrew bought 11,096 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,096
Price
$0.00
Total value
N/A
InsiderWhite Mark Andrew
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 16, 2024
Filing dateFebruary 21, 2024
Shares owned after87,758
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years.